• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    GC Biopharma and Novelty Nobility Join for Geographic Atrophy R&D

    PR NEWSWIRE

    GC Biopharma Launches ALYGLO For Primary Humoral Immunodeficiency

    PR NEWSWIRE

    KabaFusion Selected As Distribution Partner For ALYGLO™

    GLOBENEWSWIRE

    FDA Grants Fast Track Designation to GCBP and Novel Pharma`s GC1130A

    PR NEWSWIRE

    GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings

    PR NEWSWIRE

    GC Biopharma`s Sanfilippo Syndrome Treatment Gets FDA IND

    PR NEWSWIRE

    GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024

    PR NEWSWIRE

    EMA Grants ODD to GC Biopharma`s Treatment for Sanfilippo Syndrome (Type A)

    PR NEWSWIRE

    GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

    PR NEWSWIRE

    The World`s First "Recombinant Anthrax Vaccine"

    PR NEWSWIRE

    Immetas Therapeutics and GC Biopharma Announce Research Collaboration

    BUSINESSWIRE

    FDA Grants Orphan Drug Designation to GC Biopharma`s Drug Candidate

    PR NEWSWIRE

    GC Biopharma and Eubiologics enter deal to produce cholera vaccine

    PHARMACEUTICAL TECHNOLOGY

    GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics

    PR NEWSWIRE

    U.S. FDA Accepts BLA for GC Biopharma`s GC5107B, 10% Liquid)

    PR NEWSWIRE

    U.S. FDA Accepts Biologics License Application for GC Biopharma`s GC5107B

    PR NEWSWIRE

    GC Biopharma`s "GC FLU" obtains vaccine approval in Egypt

    PR NEWSWIRE

    GC Biopharma celebrates `World Hemophilia Day`

    PR NEWSWIRE

    GC Biopharma to Acquire Catalyst Biosciences Rare Disease Hematology Pipeline

    CONTRACT PHARMA

    GC Biopharma Signs Agreement with Catalyst Biosciences

    PR NEWSWIRE

    GC Biopharma Receives WHO Pre-Qualification for BARYCELA

    PR NEWSWIRE

    GC Biopharma Receives WHO Pre-Qualification for Fil-Finish Plant

    CONTRACT PHARMA

    GC Bio Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang

    PR NEWSWIRE

    Vaccine patch passes clinical test, supporting further trials

    FIERCEPHARMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.